| FRMCX | SSGSX | FRMCX / SSGSX | |
| Total Expense Ratio | 1.16 | 1.23 | 94% |
| Annual Report Gross Expense Ratio | 1.23 | 1.23 | 100% |
| Fund Existence | 31 years | 27 years | - |
| Gain YTD | 13.072 | 18.572 | 70% |
| Front Load | 6% | 6% | 96% |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 229M | 4.55B | 5% |
| Annual Yield % from dividends | 0.36 | 0.51 | 70% |
| Returns for 1 year | 3.25 | 17.30 | 19% |
| Returns for 3 years | -3.58 | 11.95 | -30% |
| Returns for 5 years | -17.92 | -0.56 | 3,222% |
| Returns for 10 years | -18.55 | 41.05 | -45% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USTB | 50.40 | N/A | N/A |
| VictoryShares Short-Term Bond ETF | |||
| ISMD | 49.02 | -0.17 | -0.35% |
| Inspire Small/Mid Cap ETF | |||
| RTRE | 24.63 | -0.09 | -0.37% |
| Rareview Total Return Bond ETF | |||
| IDYN | 29.80 | -0.21 | -0.71% |
| iShares Intl Eq Fac Rotation Act ETF | |||
| BBC | 51.34 | -1.82 | -3.43% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||